These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6310435)

  • 21. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of specific high-affinity binding sites for [3H]imipramine in human brain.
    Langer SZ; Javoy-Agid F; Raisman R; Briley M; Agid Y
    J Neurochem; 1981 Aug; 37(2):267-71. PubMed ID: 7264658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns.
    Duncan GE; Little KY; Kirkman JA; Kaldas RS; Stumpf WE; Breese GR
    Brain Res; 1992 Sep; 591(2):181-97. PubMed ID: 1332802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermodynamics of the interactions of tricyclic drugs with binding sites for [3H]imipramine in mouse cerebral cortex.
    Reith ME; Sershen H; Lajtha A
    Biochem Pharmacol; 1984 Dec; 33(24):4101-4. PubMed ID: 6095869
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of seasonal variation in platelet [3H]imipramine binding in humans.
    Galzin AM; Lôo H; Sechter D; Langer SZ
    Biol Psychiatry; 1986 Aug; 21(10):876-82. PubMed ID: 3017462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The detection of specific [3H]imipramine binding in bovine retina.
    Borbe HO; Zube I
    Brain Res; 1983 Mar; 264(1):178-80. PubMed ID: 6303498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: in rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sites.
    Barbaccia ML; Melloni P; Pozzi O; Costa E
    Eur J Pharmacol; 1986 Apr; 123(1):45-52. PubMed ID: 3011457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific high affinity [3H]imipramine binding sites in rat lung are associated with a non-neuronal uptake site for serotonin.
    Raisman R; Langer SZ
    Eur J Pharmacol; 1983 Oct; 94(3-4):345-8. PubMed ID: 6317406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal study of intact platelet 3H-imipramine binding in 12 normal human subjects.
    Goziotis A; Tang SW
    Psychiatry Res; 1988 Nov; 26(2):157-62. PubMed ID: 2853400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unaltered platelet [3H]-imipramine binding in dementia of the Alzheimer type.
    Weizman R; Dick J; Mosek A; Tyano S; Rehavi M
    Neuropsychobiology; 1988; 19(2):69-72. PubMed ID: 2852311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional analysis of 5-HT1A and 5-HT2 receptors in the fawn-hooded rat.
    Hulihan-Giblin BA; Park YD; Aulakh CS; Goldman D
    Neuropharmacology; 1992 Nov; 31(11):1095-9. PubMed ID: 1475019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of ligand binding to membranes by a soluble acceptor. Alpha-1-acid glycoprotein attenuates 3H-imipramine binding to cerebral membranes.
    Barkai AI; Baron M; Kowalik S; Cooper TB
    Biol Psychiatry; 1986 Aug; 21(10):883-8. PubMed ID: 2427130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of 3H-imipramine binding sites in rat cerebral cortex after prenatal exposure to antidepressants.
    Montero D; de Ceballos ML; Del Rio J
    Life Sci; 1990; 46(22):1619-26. PubMed ID: 2161976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5134-8. PubMed ID: 6308674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.